PortfoliosLab logoPortfoliosLab logo
PBE vs. PBD
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

PBE vs. PBD - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Invesco Dynamic Biotechnology & Genome ETF (PBE) and Invesco Global Clean Energy ETF (PBD). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, PBE achieves a 0.58% return, which is significantly lower than PBD's 38.50% return. Over the past 10 years, PBE has underperformed PBD with an annualized return of 7.55%, while PBD has yielded a comparatively higher 9.45% annualized return.


PBE

1D
2.04%
1M
2.68%
YTD
0.58%
6M
1.15%
1Y
30.26%
3Y*
10.44%
5Y*
3.06%
10Y*
7.55%

PBD

1D
-0.93%
1M
6.10%
YTD
38.50%
6M
39.82%
1Y
92.04%
3Y*
8.96%
5Y*
-3.66%
10Y*
9.45%
*Multi-year figures are annualized to reflect compound growth (CAGR)

PBE vs. PBD - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
PBE
Invesco Dynamic Biotechnology & Genome ETF
0.58%24.84%1.10%3.71%-10.83%1.54%25.66%18.65%-0.19%22.28%
PBD
Invesco Global Clean Energy ETF
38.50%43.65%-26.39%-10.69%-29.70%-22.30%145.46%40.00%-19.32%28.72%

Correlation

The correlation between PBE and PBD is 0.41, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.41

Correlation (3Y)
Calculated over the trailing 3-year period

0.49

Correlation (5Y)
Calculated over the trailing 5-year period

0.56

Correlation (10Y)
Calculated over the trailing 10-year period

0.51

Correlation (All Time)
Calculated using the full available price history since Jun 14, 2007

0.55

The correlation between PBE and PBD shifts across timeframes, from 0.41 (1 year) to 0.56 (5 years), reflecting how their relationship changes across market environments.

PBE vs. PBD - Sectors Allocation Comparison


Sectors
PBE
PBD

Healthcare

100.0%

-

Financial Services

0.0%
1.2%

Basic Materials

-

3.4%

Communication Services

-

-

Consumer Cyclical

-

9.4%

Consumer Defensive

-

0.9%

Energy

-

12.4%

Industrials

-

48.1%

Real Estate

-

-

Technology

-

6.8%

Utilities

-

12.0%

Healthcare

PBE
100.0%
PBD

-

Financial Services

PBE
0.0%
PBD
1.2%

Basic Materials

PBE

-

PBD
3.4%

Communication Services

PBE

-

PBD

-

Consumer Cyclical

PBE

-

PBD
9.4%

Consumer Defensive

PBE

-

PBD
0.9%

Energy

PBE

-

PBD
12.4%

Industrials

PBE

-

PBD
48.1%

Real Estate

PBE

-

PBD

-

Technology

PBE

-

PBD
6.8%

Utilities

PBE

-

PBD
12.0%

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

PBE vs. PBD — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

PBE
PBE Risk / Return Rank: 4747
Overall Rank
PBE Sharpe Ratio Rank: 4646
Sharpe Ratio Rank
PBE Sortino Ratio Rank: 4949
Sortino Ratio Rank
PBE Omega Ratio Rank: 4444
Omega Ratio Rank
PBE Calmar Ratio Rank: 5252
Calmar Ratio Rank
PBE Martin Ratio Rank: 4444
Martin Ratio Rank

PBD
PBD Risk / Return Rank: 9494
Overall Rank
PBD Sharpe Ratio Rank: 9595
Sharpe Ratio Rank
PBD Sortino Ratio Rank: 9393
Sortino Ratio Rank
PBD Omega Ratio Rank: 9191
Omega Ratio Rank
PBD Calmar Ratio Rank: 9595
Calmar Ratio Rank
PBD Martin Ratio Rank: 9494
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

PBE vs. PBD - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Invesco Dynamic Biotechnology & Genome ETF (PBE) and Invesco Global Clean Energy ETF (PBD). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


PBEPBDDifference
Sharpe ratioReturn per unit of total volatility

-2.33

Sortino ratioReturn per unit of downside risk

-2.20

Omega ratioGain probability vs. loss probability

1.28

1.61

-0.32

Calmar ratioReturn relative to maximum drawdown

2.59

8.65

-6.05

Martin ratioReturn relative to average drawdown

7.27

26.96

-19.69

PBE vs. PBD - Sharpe Ratio Comparison

The current PBE Sharpe Ratio is 1.63, which is lower than the PBD Sharpe Ratio of 3.96. The chart below compares the historical Sharpe Ratios of PBE and PBD, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


PBEPBDDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

1.63

3.96

-2.33

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.14

-0.13

+0.27

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.30

0.35

-0.04

Sharpe Ratio (All Time)

Calculated using the full available price history

0.32

0.03

+0.30

Drawdowns

PBE vs. PBD - Drawdown Comparison

The maximum PBE drawdown since its inception was -45.69%, smaller than the maximum PBD drawdown of -78.60%. Use the drawdown chart below to compare losses from any high point for PBE and PBD.


Loading charts...

Drawdown Indicators


PBEPBDDifference

Max Drawdown

Largest peak-to-trough decline

-45.69%

-78.60%

+32.91%

Max Drawdown (1Y)

Largest decline over 1 year

-11.73%

-10.70%

-1.03%

Max Drawdown (3Y)

Largest decline over 3 years

-22.43%

-52.45%

+30.02%

Max Drawdown (5Y)

Largest decline over 5 years

-34.71%

-69.15%

+34.44%

Max Drawdown (10Y)

Largest decline over 10 years

-37.84%

-75.40%

+37.56%

Current Drawdown

Current decline from peak

-3.62%

-39.02%

+35.40%

Average Drawdown

Average peak-to-trough decline

-16.24%

-53.40%

+37.16%

Ulcer Index

Depth and duration of drawdowns from previous peaks

4.17%

3.43%

+0.74%

Volatility

PBE vs. PBD - Volatility Comparison

The current volatility for Invesco Dynamic Biotechnology & Genome ETF (PBE) is 5.63%, while Invesco Global Clean Energy ETF (PBD) has a volatility of 8.57%. This indicates that PBE experiences smaller price fluctuations and is considered to be less risky than PBD based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


PBEPBDDifference

Volatility (1M)

Calculated over the trailing 1-month period

5.63%

8.57%

-2.94%

Volatility (6M)

Calculated over the trailing 6-month period

13.27%

17.00%

-3.73%

Volatility (1Y)

Calculated over the trailing 1-year period

18.71%

23.41%

-4.70%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

22.54%

28.37%

-5.83%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

24.92%

27.26%

-2.34%

PBE vs. PBD - Expense Ratio Comparison

PBE has a 0.59% expense ratio, which is lower than PBD's 0.75% expense ratio.


Dividends

PBE vs. PBD - Dividend Comparison

PBE's dividend yield for the trailing twelve months is around 1.05%, less than PBD's 1.63% yield.


PositionTTM20252024202320222021202020192018201720162015
PBD
Invesco Global Clean Energy ETF
1.63%2.71%1.81%2.85%2.98%0.67%0.48%1.83%1.86%1.76%2.04%1.24%
PBE
Invesco Dynamic Biotechnology & Genome ETF
1.05%1.00%0.05%0.02%0.00%0.00%0.04%0.00%0.00%0.57%0.38%1.12%

Frequently Asked Questions


PBE and PBD have a correlation of 0.41, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

PBD has higher volatility (8.57%) compared to PBE (5.63%). In terms of maximum drawdown, PBE dropped -45.69% vs PBD's -78.60%.

On 10-year performance, PBD leads with 9.45% vs 7.55% for PBE. On fees, PBE is cheaper at 0.59% per year. On volatility, PBE has been the lower-risk option at 5.63%. The better choice depends on whether you care most about return, fees, risk, or income.

Over the 10-year period, PBD has performed better with a 9.45% return vs 7.55%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.

PBE is cheaper with a 0.59% expense ratio, compared with 0.75% for PBD.

PBD has the higher dividend yield at 1.63%, compared with 1.05% for PBE.

PBE is categorized as Health & Biotech Equities, while PBD is Alternative Energy Equities. PBE tracks Dynamic Biotech & Genome Intellidex Index (AMEX), while PBD tracks WilderHill New Energy Global Innovation index. Their fees differ too: 0.59% for PBE and 0.75% for PBD.

PBD currently has the higher Sharpe Ratio (3.96 vs 1.63), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for PBE and PBD

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer